Plastic Surgeon Announces Historic Medical Milestone

Our Bureau

In a historic milestone for the field of cosmetic breast surgery, we are delighted to announce the formation of the American Association of Cosmetic Breast Surgeons (AACBS). This visionary organization, dedicated to advancing the art and science of cosmetic breast surgery, proudly welcomes Dr. John Zannis, a distinguished Plastic Surgeon, […]

Unlocking the Future of Drug Discovery with Artificial Intelligence

Our Bureau

BCC’s newly released report, titled “Global Artificial Intelligence in Drug Discovery Market,” unveils the extraordinary impact of artificial intelligence (AI) on the pharmaceutical and biotech sectors. Authored by Ms. Surbhi Jagtap, Senior Analyst, this study provides invaluable insights into the AI-driven revolution in drug discovery. BOSTON, Sept. 22, 2023 /PRNewswire/ […]

PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) Significantly Improve Overall Survival and Progression-Free Survival in Patients With Previously Untreated Advanced Bladder Cancer in Pivotal Phase 3 EV-302 Trial

Our Bureau

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced positive topline results from the Phase 3 EV-302 clinical trial (also known as KEYNOTE-A39) for PADCEV® (enfortumab vedotin-ejfv) in combination with KEYTRUDA® (pembrolizumab) versus chemotherapy in patients with previously untreated locally advanced or […]

Combining best-in-class AI-powered Technologies for Musculoskeletal (MSK) Imaging Workflows – ImageBiopsy Lab and Radiobotics sign Collaboration Agreement

Our Bureau

ImageBiopsy Lab (Vienna, Austria) and Radiobotics (Copenhagen, Denmark) have teamed up to advance the use of Artificial-Intelligence (AI) supported disease diagnostics for musculoskeletal (MSK), orthopaedic, and trauma use-cases in the DACH region. Globally, musculoskeletal conditions affect a larger population than circulatory or respiratory disorders. Despite this, diagnostic methods often remain […]

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

Our Bureau

MicuRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies for treating life-threatening infections, today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) and the Fast Track Designation under the Generating Antibiotic Incentives Now (GAIN) Act […]

Life Time Expands to Connecticut with First Athletic Country Club and Life Time Living Luxury Residences in Downtown Stamford

Our Bureau

Life Time (NYSE:LTH), the nation’s premier healthy lifestyle brand, today opened its first athletic country club in Connecticut with a nearly 52,000-square foot athletic country club and 10,000-square-foot rooftop beach club in downtown Stamford. The vertically integrated tower featuring 290 luxury residences for lease also opened, licensed under the Life […]

Subscribe Now